Targeting Promoter-Associated Noncoding RNA In Vivo

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• Noncoding RNAs (ncRNAs), including microRNAs (miRNAs) and long ncRNAs (lncRNAs), play crucial roles in cellular processes and gene regulation.
• Dysregulation of lncRNAs is associated with diseases like cancer, where they can influence oncogenes such as c-Myc.
• Antisense oligonucleotides and small interfering RNA (siRNA) are methods to modulate lncRNA function.

Purpose of the Study:

• To investigate the potential of targeting promoter-associated lncRNAs with siRNAs for therapeutic applications.
• To evaluate the efficacy of in vivo-jetPEI™ as a delivery vehicle for nucleic acids, including siRNAs.

Main Methods:

• Utilized siRNA to block lncRNA transcription, a method with growing clinical interest.
• Employed in vivo-jetPEI™, a linear polyethylenimine, for efficient delivery of nucleic acids.
• Validated various in vivo delivery routes (IV, IP, intratumoral, etc.) and confirmed siRNA detection in target tissues via qRT-PCR.

Main Results:

• in vivo-jetPEI™ demonstrated high efficiency in delivering nucleic acids to a wide range of tissues, including lung, liver, and prostate.
• The delivery system proved effective for both systemic and local gene and siRNA delivery.
• siRNA levels in target tissues were successfully validated post-systemic injection.

Conclusions:

• Targeting promoter-associated lncRNAs with siRNAs in vivo represents a significant advancement in treating human diseases.
• in vivo-jetPEI™ is a versatile and efficient tool for in vivo nucleic acid delivery, paving the way for novel therapeutic strategies.